Israel
Intelligence de marché des dispositifs médicaux pour Israel. Changements réglementaires, concurrents et tendances d'achats.
Signaux récents
Alpha Tau Medical is developing an alpha radiation emitter device for treating vulvar squamous cell carcinoma.
Asensus Surgical, Inc. has registered a product with FDA under code NAY.
The Eraser Tattoo Removal Device is evaluated for safety and effectiveness in a clinical study with 20 patients.
The Nit-Occlud® Lê VSD Spiral Coil System is evaluated for safety and effectiveness in VSD treatment across multiple countries.
Olympus acquires BioProtect for $270M to enhance prostate cancer care with biodegradable balloon spacers.
A study will compare metabolic outcomes in gestational diabetes using the LUMEN device versus a mobile app.
The PainShield device uses ultrasound technology to assess postoperative pain relief and wound healing after surgery.
A new device evaluates lung photoplethysmography in various patient groups, including neonates with pulmonary conditions.
The Endorings-2 accessory aims to improve adenoma detection rates in colonoscopy, addressing a 25% miss rate.
The Su2ura Approximation Device was evaluated for umbilical hernia repair in a study involving 45 patients across three centers.
A study evaluates the safety and efficacy of the PulseNmore FC device in IVF treatment for 100 women.
The PMD-200 pain monitor study at a neurointensive care unit has been terminated.
Emerging technologies are redefining the medical device landscape, as noted by entrepreneur Eyal Lifschitz.
The EUM device was validated as a reliable non-invasive method for monitoring uterine contractions and fetal heart rate.
A study is recruiting to evaluate the WP device against PSG for detecting sleep disorders.
The study compares the WatchPAT device to PSG for diagnosing obstructive sleep apnea in patients aged 5 to 90.
A study on the REN device shows potential preventive benefits for migraines in adolescents through frequent use.
The Serenno Medical device aims to automate urine output and IAP measurements for improved accuracy in critical care.
The Hanita CleaRing device reduces Nd:YAG treatment rates in cataract patients by inhibiting PCO post-lens extraction.
A study investigates a white light imaging device for 3D ocular tissue imaging, focusing on dry eye syndrome.